Year archive

Galapagos NV — 2016 filings

All 217 regulatory filings released by Galapagos NV (GLPG) in 2016, sourced directly from the official regulator.

217 Filings

2016 Period

2016 filings (217)

Filing	Released	Lang
SAPHIRA 1 topline shows competitive clinical results in G551D patients Earnings Release FY 2016	2016-12-21	English
SAPHIRA 1 topline shows competitive clinical results in G551D patients Earnings Release Q4 2016	2016-12-21	English
6-K Filing Foreign Filer Report	2016-12-21	English
SAPHIRA 1 toont competitieve klinische resultaten in G551D patiënten Earnings Release FY 2016	2016-12-20	Dutch
6-K Filing Foreign Filer Report	2016-12-19	English
The Lancet publishes FITZROY study results with filgotinib in Crohn's disease Regulatory Filings	2016-12-15	English
The Lancet publishes FITZROY study results with filgotinib in Crohn's disease Regulatory Filings	2016-12-15	English
6-K Filing Foreign Filer Report	2016-12-12	English
Start Phase 2b/3 study with filgotinib in ulcerative colitis Regulatory Filings	2016-12-09	English
Start Phase 2b/3 study with filgotinib in ulcerative colitis Legal Proceedings Report	2016-12-09	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-11-30	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-11-30	English
Galapagos initiates Phase 1 study with cystic fibrosis drug GLPG2737 Regulatory Filings	2016-11-29	English
Galapagos initiates Phase 1 study with cystic fibrosis drug GLPG2737 Regulatory Filings	2016-11-29	English
6-K Filing Foreign Filer Report	2016-11-29	English
6-K Filing Foreign Filer Report	2016-11-29	English
Share Capital Increase - 28 November 2016_EN.pdf Share Issue/Capital Change	2016-11-29	English
Share Capital Increase - 28 november 2016_NL.pdf Share Issue/Capital Change	2016-11-29	Dutch
Initiation of Phase 1 with CF drug GLPG2737 Regulatory Filings	2016-11-28	English
Start of Fase 1 met CF medicijn GLPG2737 Regulatory Filings	2016-11-28	Dutch
6-K Filing Foreign Filer Report	2016-11-25	English
Galapagos selected for Stoxx Europe 600 Index Regulatory Filings	2016-11-24	English
Galapagos selected for Stoxx Europe 600 Index Regulatory Filings	2016-11-24	English
Phase 3 study with filgotinib initiated in Crohn's disease Regulatory Filings	2016-11-23	English
Phase 3 study with filgotinib initiated in Crohn's disease Regulatory Filings	2016-11-23	English
6-K Filing Foreign Filer Report	2016-11-23	English
Start Phase 3 filgotinib in CD Regulatory Filings	2016-11-23	English
Start Phase 3 filgotinib in CD Regulatory Filings	2016-11-23	Dutch
6-K Filing Foreign Filer Report	2016-11-09	English
6-K Filing Foreign Filer Report	2016-11-09	English
6-K Filing Foreign Filer Report	2016-11-09	English
Robust progress in Q3 2016 Earnings Release 9M 2016	2016-10-28	English
Robust progress in Q3 2016 Earnings Release 9M 2016	2016-10-28	English
Robust progress in Q3 2016.pdf Report Publication Announcement	2016-10-27	English
Sterke vooruitgang in derde kwartaal van 2016.pdf Earnings Release 9M 2016	2016-10-27	Dutch
Q3 report 2016.pdf Interim / Quarterly Report 9M 2016	2016-10-27	English
Q3 verslag 2016.pdf Interim / Quarterly Report 9M 2016	2016-10-27	Dutch
Galapagos to present progress in CF programs at NACFC 2016 Regulatory Filings	2016-10-27	English
Galapagos to present progress in CF programs at NACFC 2016 Regulatory Filings	2016-10-27	English
Robust progress Q3 Earnings Release 9M 2016	2016-10-27	English
Sterke vooruitgang Q3 Earnings Release 9M 2016	2016-10-27	Dutch
Transparency notification - FMR LLC reaches 10% threshold Declaration of Voting Results & Voting Rights Announcements	2016-10-13	English
Transparency notification - FMR LLC reaches 10% threshold Major Shareholding Notification	2016-10-13	English
FMR_TP_12Oct2016_DEF.pdf Major Shareholding Notification	2016-10-12	English
FMR TP _12Oct2016 NL.pdf Major Shareholding Notification	2016-10-12	Dutch
6-K Filing Foreign Filer Report	2016-10-05	English
MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis Regulatory Filings	2016-09-29	English
MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis Legal Proceedings Report	2016-09-29	English
Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease Regulatory Filings	2016-09-28	English
Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease Regulatory Filings	2016-09-28	English
6-K Filing Foreign Filer Report	2016-09-27	English
Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease Regulatory Filings	2016-09-27	English
Succesvolle afronding overleg met regelgevende autoriteiten voor Fase 3 met filgotinib in darmziekten (IBD) Regulatory Filings	2016-09-27	Dutch
Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's disease Earnings Release Q3 2016	2016-09-26	English
Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's disease Earnings Release Q3 2016	2016-09-26	English
Endoscopische verbeteringen met filgotinib in lijn met klinische remissie bij de ziekte van Crohn Earnings Release Q3 2016	2016-09-26	Dutch
Endoscopic improvements with filgotinib are consistent with Regulatory Filings	2016-09-26	English
Endoscopische verbeteringen met filgotinib in lijn met klinische remissie bij de ziekte van Crohn Legal Proceedings Report	2016-09-26	Dutch
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-09-20	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-09-20	English
Share Capital Increase - 19 September 2016_EN.pdf Share Issue/Capital Change	2016-09-19	English
Share Capital Increase - 19 September 2016_NL.pdf Share Issue/Capital Change	2016-09-19	Dutch
Orphan Drug Designation in European Union for GLPG1690 in idiopathic pulmonary fibrosis Regulatory Filings	2016-09-06	English
Orphan Drug Designation in European Union for GLPG1690 in idiopathic pulmonary fibrosis Regulatory Filings	2016-09-06	English
FINCH filgotinib Phase 3 program initiated in rheumatoid arthritis Regulatory Filings	2016-08-23	English
FINCH filgotinib Phase 3 program initiated in rheumatoid arthritis Regulatory Filings	2016-08-23	English
6-K Filing Foreign Filer Report	2016-08-01	English
6-K Filing Foreign Filer Report	2016-08-01	English
Federated TP July 16 NL _FINAL.pdf Major Shareholding Notification	2016-07-29	Dutch
Focus on filgotinib and cystic fibrosis Earnings Release H1 2016	2016-07-28	English
Focus op filgotinib en cystic fibrose Earnings Release H1 2016	2016-07-28	Dutch
nxr_glpg_q216_FINAL_en.pdf Interim / Quarterly Report H1 2016	2016-07-28	English
nxr_glpg_q216_FINAL_nl.pdf Interim / Quarterly Report H1 2016	2016-07-28	Dutch
6-K Filing Foreign Filer Report	2016-07-14	English
6-K Filing Foreign Filer Report	2016-06-29	English
Invitation to the Special and Extraordinary Shareholders' Meetings of 26 July 2016 - Nomination of Mary Kerr for Galapagos' Board of Directors AGM Information	2016-06-23	English
Invitation to the Special and Extraordinary Shareholders' Meetings of 26 July 2016 - Nomination of Mary Kerr for Galapagos' Board of Directors AGM Information	2016-06-23	English
6. Shares and Voting Rights (NL-EN).pdf Share Issue/Capital Change	2016-06-23	Dutch
2. Proxy Forms (NL-EN).pdf Proxy Solicitation & Information Statement	2016-06-23	Dutch
3. Attendance Notification Form (NL-EN).pdf AGM Information	2016-06-23	Dutch
5. BoD Report - 604 - Authorized Capital (NL).pdf Proxy Solicitation & Information Statement	2016-06-23	Dutch
5. BoD Report - 604 - Authorized Capital (EN).pdf AGM Information	2016-06-23	English
4. Professional Qualifications Mary Kerr (NL-EN).pdf Board/Management Information	2016-06-23	Dutch
PR EGM 26 July 2016_EN.pdf AGM Information	2016-06-23	English
PR EGM 26 July 2016_NL.pdf AGM Information	2016-06-23	Dutch
1. Convening Notice (EN).pdf AGM Information	2016-06-23	English
1. Convening Notice (NL).pdf AGM Information	2016-06-23	Dutch
Galapagos creates new warrant plan Share Issue/Capital Change	2016-06-21	English
Galapagos creates new warrant plan Share Issue/Capital Change	2016-06-21	English
6-K Filing Foreign Filer Report	2016-06-17	English
Galapagos' R&D Update 2016 Investor Presentation	2016-06-15	English
Galapagos' R&D Update 2016 Investor Presentation	2016-06-15	English
Galapagos' R&D Update Investor Presentation	2016-06-15	English
Galapagos R&D Update Investor Presentation	2016-06-15	Dutch
Galapagos selected for AEX Index Regulatory Filings	2016-06-09	English
Galapagos selected for AEX Index Regulatory Filings	2016-06-09	English
S-8 Filing Registration Form	2016-06-03	English
6-K Filing Foreign Filer Report	2016-06-02	English
6-K Filing Foreign Filer Report	2016-06-01	English
Press Release Warrant Plan 2016.pdf Share Issue/Capital Change	2016-06-01	English
Press Release Warrant Plan 2016_NL.pdf Share Issue/Capital Change	2016-06-01	Dutch
FITZROY Phase 2 study with filgotinib in Crohn's Disease presented as late breaker at DDW 2016 Regulatory Filings	2016-05-26	English
FITZROY Phase 2 study with filgotinib in Crohn's Disease presented as late breaker at DDW 2016 Regulatory Filings	2016-05-26	English
Successful completion of End-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis (RA) Regulatory Filings	2016-05-25	English
Successful completion of End-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis (RA) Earnings Release Q2 2016	2016-05-25	English
6-K Filing Foreign Filer Report	2016-05-25	English
6-K Filing Foreign Filer Report	2016-05-25	English
Successful completion of End-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis (RA) Earnings Release Q2 2016	2016-05-24	English
Succesvolle afronding Eind Fase 2 overleg met FDA en EMA voor reuma Regulatory Filings	2016-05-24	Dutch
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-05-20	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-05-20	English
Share Capital Increase - 19 May 2016_EN_Final.pdf Share Issue/Capital Change	2016-05-19	English
Share Capital Increase - 19 May 2016_NL_Final.pdf Share Issue/Capital Change	2016-05-19	Dutch
Galapagos increases share capital through warrant exercises Declaration of Voting Results & Voting Rights Announcements	2016-05-19	English
Galapagos verhoogt kapitaal door uitoefening van warrants Share Issue/Capital Change	2016-05-19	Dutch
Listing of Gilead shares and publication of prospectus_EN.pdf Report Publication Announcement	2016-05-17	English
Listing of Gilead shares and publication of prospectus_NL.pdf Delisting Announcement	2016-05-17	Dutch
Listing of existing shares on Euronext Brussels & Amsterdam Share Issue/Capital Change	2016-05-17	English
Listing of existing shares on Euronext Brussels & Amsterdam Report Publication Announcement	2016-05-17	English
6-K Filing Foreign Filer Report	2016-05-17	English
Listing of existing shares on Euronext Brussels & Amsterdam Report Publication Announcement	2016-05-17	English
Toelating bestaande aandelen op Euronext Brussel & Amsterdam Delisting Announcement	2016-05-17	Dutch
6-K Filing Foreign Filer Report	2016-05-11	English
Galapagos starts Phase 1 study with potentiator GLPG2451 for CF Regulatory Filings	2016-05-10	English
Galapagos starts Phase 1 study with potentiator GLPG2451 for CF Earnings Release Q2 2016	2016-05-10	English
Galapagos start Fase 1 studie met kandidaatmedicijn GLPG2451 voor CF Earnings Release Q2 2016	2016-05-09	Dutch
6-K Filing Foreign Filer Report	2016-05-02	English
6-K Filing Foreign Filer Report	2016-05-02	English
Galapagos kick-starts 2016 with Q1 cash position of €988 M Earnings Release Q1 2016	2016-04-29	English
Galapagos kick-starts 2016 with Q1 cash position of €988 M Earnings Release Q1 2016	2016-04-29	English
Galapagos and AbbVie expand their cystic fibrosis collaboration Regulatory Filings	2016-04-29	English
Galapagos and AbbVie expand their cystic fibrosis collaboration Regulatory Filings	2016-04-29	English
Galapagos en AbbVie breiden hun samenwerking in cystic fibrosis uit Regulatory Filings	2016-04-29	Dutch
Q1 16 EN.pdf Interim / Quarterly Report Q1 2016	2016-04-28	English
Q1 16 NL.pdf Interim / Quarterly Report Q1 2016	2016-04-28	Dutch
Q1 16_final.pdf Earnings Release Q1 2016	2016-04-28	English
Q1 16 _final_NL.pdf Earnings Release Q1 2016	2016-04-28	Dutch
Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study Earnings Release Q2 2016	2016-04-22	English
Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study Regulatory Filings	2016-04-22	English
6-K Filing Foreign Filer Report	2016-04-22	English
Galapagos rapporteert aanvullende data over filgotinib uit de Fase 2 FITZROY studie Earnings Release Q2 2016	2016-04-21	Dutch
Galapagos and MorphoSys initiate Phase 1 study in joint antibody program MOR106 Regulatory Filings	2016-04-07	English
Galapagos and MorphoSys initiate Phase 1 study in joint antibody program MOR106 Investor Presentation	2016-04-07	English
Galapagos en MorphoSys starten Fase 1 studie met gezamenlijk antilichaamprogramma MOR106 Regulatory Filings	2016-04-07	Dutch
Galapagos initiates a Phase 2a study with GLPG1690 in idiopathic pulmonary fibrosis patients Regulatory Filings	2016-04-07	English
Galapagos initiates a Phase 2a study with GLPG1690 in idiopathic pulmonary fibrosis patients Regulatory Filings	2016-04-07	English
6-K Filing Foreign Filer Report	2016-04-07	English
6-K Filing Foreign Filer Report	2016-04-07	English
Galapagos start een Fase 2a studie met GLPG1690 bij patiënten met idiopathische longfibrose Regulatory Filings	2016-04-06	Dutch
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-04-04	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2016-04-04	English
6-K Filing Foreign Filer Report	2016-04-04	English
Share capital increase 1 April 2016_NL_FINAL.pdf Share Issue/Capital Change	2016-04-01	Dutch
Publication of the annual report and invitation to the Annual and Extraordinary Shareholders' Meetings Report Publication Announcement	2016-03-29	English
Publication of the annual report and invitation to the Annual and Extraordinary Shareholders' Meetings Report Publication Announcement	2016-03-29	English
6-K Filing Foreign Filer Report	2016-03-28	English
8. AGM-EGM 26 April 2016 - Shares and Voting Rights - D&E.pdf Share Issue/Capital Change	2016-03-25	Dutch
2. AGM-EGM 26 April 2016 - Proxy Form - D&E.pdf AGM Information	2016-03-25	Dutch
6. Auditor's Report - Non-Consolidated FS - D.pdf Audit Report / Information FY 2015	2016-03-25	Dutch
3. AGM-EGM 26 April 2016 - Attendance Notification Form - D&E.pdf AGM Information	2016-03-25	Dutch
6. Auditor's Report - Non-Consolidated FS - E.pdf Audit Report / Information FY 2015	2016-03-25	English
5. Non-consolidated financial statements per 31 December 2015 (Dutch only).pdf Annual Report FY 2015	2016-03-25	Dutch
7. BoD Report - 604 - Authorized Capital - E.pdf AGM Information	2016-03-25	English
7. BoD Report - 604 - Authorized Capital - D.pdf Proxy Solicitation & Information Statement	2016-03-25	Dutch
1. AGM-EGM 26 April 2016 - Convening Notice - E.pdf AGM Information	2016-03-25	English
1. AGM-EGM 26 April 2016 - Convening Notice - D.pdf AGM Information	2016-03-25	Dutch
Publicatie van het jaarverslag en uitnodiging voor de Gewone en Buitengewone Algemene Vergaderingen Report Publication Announcement	2016-03-25	Dutch
entire_glpg_ar15.pdf Annual Report FY 2015	2016-03-25	English
entire_glpg_jv15.pdf Annual Report FY 2015	2016-03-25	Dutch
20-F Filing Annual Report FY 2015	2016-03-25	English
6-K Filing Foreign Filer Report	2016-03-22	English
6-K Filing Foreign Filer Report	2016-03-22	English
Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCO Earnings Release Q4 2015	2016-03-18	English
Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCO Regulatory Filings	2016-03-18	English
Galapagos doses first CF patient with G551D mutation in SAPHIRA 1 study Regulatory Filings	2016-03-17	English
Galapagos doses first CF patient with G551D mutation in SAPHIRA 1 study Earnings Release Q1 2016	2016-03-17	English
Galapagos doseert eerste CF patiënt met G551D mutatie in SAPHIRA 1 studie Earnings Release Q1 2016	2016-03-16	Dutch
Galapagos selected for BEL 20 Index Regulatory Filings	2016-03-07	English
Galapagos selected for BEL 20 Index Regulatory Filings	2016-03-07	English
Galapagos reports largest cash balance ever Earnings Release FY 2015	2016-03-04	English
Galapagos reports largest cash balance ever Earnings Release FY 2015	2016-03-04	English
FY2015_FINAL.pdf Earnings Release FY 2015	2016-03-03	English
FY2015_NL_FINAL.pdf Earnings Release FY 2015	2016-03-03	Dutch
Galapagos receives transparency notification from Johnson & Johnson Major Shareholding Notification	2016-03-02	English
Galapagos receives transparency notification from Johnson & Johnson Major Shareholding Notification	2016-03-02	English
6-K Filing Foreign Filer Report	2016-03-02	English
JnJ TP NL_final.pdf Major Shareholding Notification	2016-03-01	Dutch
esma-2015-1596_standard_form_for_disclosure_of_home_member_state_GLPG.pdf Regulatory Filings	2016-02-24	Dutch
6-K Filing Foreign Filer Report	2016-02-22	English
Galapagos starts SAPHIRA Phase 2 study with GLPG1837 in cystic fibrosis patients Regulatory Filings	2016-02-17	English
Galapagos starts SAPHIRA Phase 2 study with GLPG1837 in cystic fibrosis patients Regulatory Filings	2016-02-17	English
Galapagos start SAPHIRA Fase 2 studie met GLPG1837 in patiënten met cystic fibrosis Regulatory Filings	2016-02-16	Dutch
SC 13G/A Filing Major Shareholding Notification	2016-02-16	English
SC 13G Filing Major Shareholding Notification	2016-02-11	English
6-K Filing Foreign Filer Report	2016-02-05	English
Galapagos receives transparency notification from Wellington Management Group LLP Major Shareholding Notification	2016-02-02	English
Galapagos receives transparency notification from Wellington Management Group LLP Major Shareholding Notification	2016-02-02	English
Wellington TP Final_NL.pdf Major Shareholding Notification	2016-02-01	Dutch
6-K Filing Foreign Filer Report	2016-01-27	English
Galapagos reports results with GLPG1205 in ulcerative colitis Earnings Release Q1 2016	2016-01-26	English
Galapagos reports results with GLPG1205 in ulcerative colitis Earnings Release Q1 2016	2016-01-26	Dutch
Transparency notification - Gilead Sciences, Inc. holds 14.75% of Galapagos shares Major Shareholding Notification	2016-01-25	English
Transparency notification - Gilead Sciences, Inc. holds 14.75% of Galapagos shares Major Shareholding Notification	2016-01-25	English
Transparantiepersbericht_NL_FINAL.pdf Major Shareholding Notification	2016-01-25	Dutch
6-K Filing Foreign Filer Report	2016-01-25	English
Galapagos and Gilead complete closing of their global collaboration for filgotinib M&A Activity	2016-01-20	English
Galapagos and Gilead complete closing of their global collaboration for filgotinib M&A Activity	2016-01-20	English
Deal Closing_FIN_NL.pdf M&A Activity	2016-01-19	Dutch
Galapagos advances CF clinical development Legal Proceedings Report	2016-01-19	English
Galapagos advances CF clinical development Regulatory Filings Q1 2016	2016-01-19	English
6-K Filing Foreign Filer Report	2016-01-19	English
6-K Filing Foreign Filer Report	2016-01-19	English
6-K Filing Foreign Filer Report	2016-01-19	English
Galapagos rapporteert vooruitgang in klinische ontwikkeling taaislijmziekte Earnings Release Q1 2016	2016-01-19	Dutch
Galapagos and Gilead cleared by US FTC to close their global partnership on filgotinib Capital/Financing Update	2016-01-13	English
Galapagos and Gilead cleared by US FTC to close their global partnership on filgotinib M&A Activity	2016-01-13	English
Galapagos en Gilead krijgen toestemming van de US FTC om hun wereldwijde overeenkomst voor filgotinib af te ronden M&A Activity	2016-01-12	Dutch

Filings by year

2026 99 filings
2025 162 filings
2024 118 filings
2023 121 filings
2022 167 filings
2021 183 filings
2020 156 filings
2019 324 filings
2018 205 filings
2017 196 filings
2016 217 filings
2015 187 filings
2014 183 filings
2013 142 filings
2012 105 filings
2011 124 filings
2010 42 filings
2009 39 filings
2008 31 filings
2007 27 filings
2006 15 filings
2005 12 filings